Overcoming antimicrobial resistance by targeting resistance mechanisms

被引:90
作者
Poole, K [1 ]
机构
[1] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1211/0022357011775514
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three mechanisms of antimicrobial resistance predominate in bacteria:antibiotic inactivation, target site modification, and altered uptake by way of restricted entry and/or enhanced efflux. Many of these involve enzymes OF. transport proteins whose activity can be targeted directly in an attempt to compromise resistance and, thus, potentiate antimicrobial activity. Alternatively, novel agents unaffected by these resistance mechanisms can be developed. Given the ongoing challenge posed by antimicrobial resistance in bacteria, targeting resistance in this way may be our best hope at prolonging the antibiotic era.
引用
收藏
页码:283 / 294
页数:12
相关论文
共 165 条
[31]   Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor:: Binding determinants of a potent, broad-spectrum inhibitor [J].
Concha, NO ;
Janson, CA ;
Rowling, P ;
Pearson, S ;
Cheever, CA ;
Clarke, BP ;
Lewis, C ;
Galleni, M ;
Frère, JM ;
Payne, DJ ;
Bateson, JH ;
Abdel-Meguid, SS .
BIOCHEMISTRY, 2000, 39 (15) :4288-4298
[32]   Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors [J].
Daigle, DM ;
McKay, GA ;
Wright, GD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :24755-24758
[33]   Antipneumococcal activity of ABT-773 compared to those of 10 other agents [J].
Davies, TA ;
Ednie, LM ;
Hoellman, DM ;
Pankuch, GA ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1894-1899
[34]   Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens [J].
Denis, A ;
Agouridas, C ;
Auger, JM ;
Benedetti, Y ;
Bonnefoy, A ;
Bretin, F ;
Chantot, JF ;
Dussarat, A ;
Fromentin, C ;
D'Ambrières, SG ;
Lachaud, S ;
Laurin, P ;
Le Martret, O ;
Loyau, V ;
Tessot, N ;
Pejac, JM ;
Perron, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (21) :3075-3080
[35]   Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA [J].
Douthwaite, S ;
Hansen, LH ;
Mauvais, P .
MOLECULAR MICROBIOLOGY, 2000, 36 (01) :183-192
[36]   Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].
Everett, MJ ;
Jin, YF ;
Ricci, V ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386
[37]   Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci [J].
Ferrándiz, MJ ;
Oteo, J ;
Aracil, B ;
Gómez-Garcés, JL ;
de la Campa, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2520-2523
[38]   Unanticipated inhibition of the metallo-β-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES):: A crystallographic study at 1.85-Å resolution [J].
Fitzgerald, PMD ;
Wu, JK ;
Toney, JH .
BIOCHEMISTRY, 1998, 37 (19) :6791-6800
[39]   Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus [J].
Fukuda, H ;
Hori, S ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1917-1922
[40]   The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents:: A 6-year population-based assessment [J].
Gay, K ;
Baughman, W ;
Miller, Y ;
Jackson, D ;
Whitney, CG ;
Schuchat, A ;
Farley, MM ;
Tenover, F ;
Stephens, DS .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1417-1424